Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of hepatitis B revaccination schemes in healthy non-responders
2011-005627-40Phase 4Completed
- Start
- Jul 2012
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of Hepatitis B vaccine, Recombivax HB and hepatitis b vaccine recombinant in hepatitis B (HBV) (5 arms). Primary endpoint: Primary immunogenicity. Started Jul 2012; status: completed.
02
Drugs
Hepatitis B vaccineRecombivax HBhepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on 2011-005627-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005627-40.